Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Atezolizumab + Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1
Sacramento, California
This trial is testing a combination of a special drug and precise radiation therapy for patients with early-stage lung cancer who can't have surgery. The drug boosts the immune system, and the radiation directly attacks the tumor.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service